Stevanato Group S.p.A. (STVN) vs Teleflex (TFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Teleflex (TFX) has outperformed Stevanato Group S.p.A. (STVN) over the past year, losing 3.3% versus a loss of 21.8%. Over five years, STVN leads with a -21.0% price change compared with -65.8% for TFX. Teleflex is the larger company by market cap ($5.26 billion vs $5.25 billion), about 1.0 times the size.
On valuation, Teleflex trades at a lower forward P/E (11.3x vs 23.0x for Stevanato Group S.p.A.). Teleflex pays a dividend yielding 1.10%, while Stevanato Group S.p.A. does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | STVN | TFX |
|---|---|---|
| Share price | $19.21 | $124.19 |
| Market cap | $5.25B | $5.26B |
| 1-day change | -1.18% | -0.23% |
| YTD return | -4.52% | +1.76% |
| 1-year return | -21.85% | -3.30% |
| 5-year return | -21.01% | -65.81% |
| P/E ratio (TTM) | 33.70 | — |
| Forward P/E | 23.02 | 11.34 |
| EPS (TTM) | $0.57 | $-8.48 |
| Dividend yield | 0.32% | 1.10% |
| Annual dividend | $0.00 | $1.36 |
| Revenue (latest FY) | — | $1.99B |
| Revenue growth (YoY) | — | +17.25% |
| Net income (latest FY) | — | $-905.64M |
| Gross margin | — | 56.24% |
| Operating margin | — | 5.94% |
| Net margin | — | -45.45% |
| 52-week high | $27.99 | $145.00 |
| 52-week low | $12.89 | $100.18 |
| Distance from 52-week high | -31.37% | -14.35% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +28.47% | +24.59% |
| Average volume | 370.27K | 662.34K |
| Shares outstanding | 49.83M | 42.37M |
| Employees | 6,010 | 15,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TFX has outperformed STVN by 18.5 percentage points over the past year.
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
About Teleflex
TFX stock →Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
Health Care · Medical/Dental Instruments · 15,500 employees
STVN vs TFX FAQ
Which is bigger, Stevanato Group S.p.A. or Teleflex?
Teleflex (TFX) is larger, with a market capitalization of $5.26B compared with $5.25B for Stevanato Group S.p.A. (STVN).
Which stock has performed better over the past year, STVN or TFX?
TFX returned -3.30% over the past 12 months, compared with -21.85% for STVN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Stevanato Group S.p.A. or Teleflex?
Teleflex has the higher yield at 1.10%, compared with 0.32% for Stevanato Group S.p.A..
Are Stevanato Group S.p.A. and Teleflex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.